HKEX Stock Code: 01093English|繁體|简体

1H2023 Results

  • Revenue was RMB16,080 million, an increase of 3.0% compared with the same period in 2022
  • Profit attributable to shareholders was RMB2,967 million, an increase of 0.0% compared with the same period in 2022

Highlight - 1H2023

Revenue
RMB16,080mn, +3.0%
Underlying profit attributable to shareholders
RMB3,162mn, +3.0%
Profit attributable to shareholders
RMB2,967mn, +0.0%
Basic earnings per share
RMB24.95 cents, +0.2%

Corporate Governance

Corporate Governance

Financial Calendar

Aug
23
Aug
23
May
31
Mar
22
Mar
22

Financial Reports

Financial Reports

Financial Summary

Financial Summary

IR Contacts

Address : Suite 3206, 32/F, Central Plaza,
18 Harbour Road, Wanchai, Hong Kong
Tel : (852) 2500 3144
Fax : (852) 2802 4552
E-mail : ir@cspc.hk
© Copyright 2023 CSPC Pharmaceutical Group Limited. All Rights Reserved.